374 related articles for article (PubMed ID: 31845111)
1. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma.
Kamiyango W; Villiera J; Silverstein A; Peckham-Gregory E; Campbell LR; El-Mallawany NK
Cancer Metastasis Rev; 2019 Dec; 38(4):749-758. PubMed ID: 31845111
[TBL] [Abstract][Full Text] [Related]
2. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
[TBL] [Abstract][Full Text] [Related]
3. Pediatric Kaposi sarcoma in context of the HIV epidemic in sub-Saharan Africa: current perspectives.
El-Mallawany NK; McAtee CL; Campbell LR; Kazembe PN
Pediatric Health Med Ther; 2018; 9():35-46. PubMed ID: 29722363
[TBL] [Abstract][Full Text] [Related]
4. Endemic Kaposi sarcoma in HIV-negative children and adolescents: an evaluation of overlapping and distinct clinical features in comparison with HIV-related disease.
El-Mallawany NK; Villiera J; Kamiyango W; Peckham-Gregory EC; Scheurer ME; Allen CE; McAtee CL; Legarreta A; Dittmer DP; Kovarik CL; Chiao EY; Martin SC; Ozuah NW; Mehta PS; Kazembe PN
Infect Agent Cancer; 2018; 13():33. PubMed ID: 30455728
[TBL] [Abstract][Full Text] [Related]
5. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study.
El-Mallawany NK; Kamiyango W; Slone JS; Villiera J; Kovarik CL; Cox CM; Dittmer DP; Ahmed S; Schutze GE; Scheurer ME; Kazembe PN; Mehta PS
PLoS One; 2016; 11(4):e0153335. PubMed ID: 27082863
[TBL] [Abstract][Full Text] [Related]
6. Clinical presentation and outcome of epidemic Kaposi sarcoma in Ugandan children.
Gantt S; Kakuru A; Wald A; Walusansa V; Corey L; Casper C; Orem J
Pediatr Blood Cancer; 2010 May; 54(5):670-4. PubMed ID: 20205254
[TBL] [Abstract][Full Text] [Related]
7. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania.
Campbell LR; Silverstein A; Peckham-Gregory E; Kamiyango W; Villiera J; McAtee CL; Bacha JM; Kovarik CL; Mehta PS; Chanroo T; Kapesa A; Malingoti B; Mzikamanda R; Ozuah NW; Allen CE; Scheurer ME; El-Mallawany NK
HIV Med; 2023 Jun; 24(6):664-675. PubMed ID: 36627111
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes for children and adolescents with Kaposi sarcoma.
Silverstein A; Kamiyango W; Villiera J; Peckham-Gregory EC; McAtee CL; Scheurer ME; Cox CM; Kovarik CL; Campbell LR; Allen CE; Mehta PS; Kazembe PN; Ozuah NW; El-Mallawany NK
HIV Med; 2022 Feb; 23(2):197-203. PubMed ID: 34634187
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
10. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma.
Schalling M; Ekman M; Kaaya EE; Linde A; Biberfeld P
Nat Med; 1995 Jul; 1(7):707-8. PubMed ID: 7585156
[TBL] [Abstract][Full Text] [Related]
11. Kaposi sarcoma in HIV-seronegative children presenting to the paediatric oncology ward in The Queen Elizabeth Central Hospital, Blantyre, Malawi during 2002-2014.
Mittermayer-Vassallo K; Banda K; Molyneux EM
Trop Doct; 2016 Jul; 46(3):138-42. PubMed ID: 26620689
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection.
Ziegler JL; Katongole-Mbidde E
Int J Cancer; 1996 Jan; 65(2):200-3. PubMed ID: 8567117
[TBL] [Abstract][Full Text] [Related]
13. AIDS-Kaposi Sarcoma and Classic Kaposi Sarcoma: are different ultrasound patterns related to different variants?
Solivetti FM; Elia F; Latini A; Cota C; Cordiali-Fei P; Di Carlo A
J Exp Clin Cancer Res; 2011 Apr; 30(1):40. PubMed ID: 21489270
[TBL] [Abstract][Full Text] [Related]
14. Treatment of Kaposi sarcoma in children with HIV-1 infection.
Anglemyer A; Agrawal AK; Rutherford GW
Cochrane Database Syst Rev; 2014 Jan; (1):CD009826. PubMed ID: 24464843
[TBL] [Abstract][Full Text] [Related]
15. The role of Kaposi sarcoma-associated herpesvirus in the pathogenesis of Kaposi sarcoma.
Gramolelli S; Schulz TF
J Pathol; 2015 Jan; 235(2):368-80. PubMed ID: 25212381
[TBL] [Abstract][Full Text] [Related]
16. Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease.
Caro-Vegas C; Peng A; Juarez A; Silverstein A; Kamiyango W; Villiera J; McAtee CL; Mzikamanda R; Tomoka T; Peckham-Gregory EC; Moorad R; Kovarik CL; Campbell LR; Mehta PS; Kazembe PN; Allen CE; Scheurer ME; Ozuah NW; Dittmer DP; El-Mallawany NK
JCI Insight; 2023 Nov; 8(22):. PubMed ID: 37991023
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana.
Cox CM; El-Mallawany NK; Kabue M; Kovarik C; Schutze GE; Kazembe PN; Mehta PS
Pediatr Blood Cancer; 2013 Aug; 60(8):1274-80. PubMed ID: 23487320
[TBL] [Abstract][Full Text] [Related]
18. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic challenges of oral and cutaneous Kaposi's sarcoma in resource-constrained settings.
Speicher DJ; Wanzala P; D'Lima M; Njiru A; Chindia M; Dimba E; Johnson NW
J Oral Pathol Med; 2015 Nov; 44(10):842-9. PubMed ID: 25782476
[TBL] [Abstract][Full Text] [Related]
20. A prospective cohort study identifies two types of HIV+ Kaposi Sarcoma lesions: proliferative and inflammatory.
Moorad R; Kasonkanji E; Gumulira J; Gondwe Y; Dewey M; Pan Y; Peng A; Pluta LJ; Kudowa E; Nyasosela R; Tomoka T; Tweya H; Heller T; Gugsa S; Phiri S; Moore DT; Damania B; Painschab M; Hosseinipour MC; Dittmer DP
Int J Cancer; 2023 Dec; 153(12):2082-2092. PubMed ID: 37602960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
